PTGS2 and lung carcinoma: Preclinical studies have confirmed that 3’-methylated HQi-sRNA-2 significantly inhibits the proliferation, migration, and invasion of NCI-H460 human lung cancer cells by targeting COX-2/PTGS2 and downregulating the PI3K/AKT signaling pathways.